Literature DB >> 18054314

Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease.

Carlos Fernández-Hernando1, Eric Ackah, Jun Yu, Yajaira Suárez, Takahisa Murata, Yasuko Iwakiri, Jay Prendergast, Robert Q Miao, Morris J Birnbaum, William C Sessa.   

Abstract

The Akt signaling pathway controls several cellular functions in the cardiovascular system; however, its role in atherogenesis is unknown. Here, we show that the genetic ablation of Akt1 on an apolipoprotein E knockout background (ApoE(-/-)Akt1(-/-)) increases aortic lesion expansion and promotes coronary atherosclerosis. Mechanistically, lesion formation is due to the enhanced expression of proinflammatory genes and endothelial cell and macrophage apoptosis. Bone marrow transfer experiments showing that macrophages from ApoE(-/-)Akt1(-/-) donors were not sufficient to worsen atherogenesis when transferred to ApoE(-/-) recipients suggest that lesion expansion in the ApoE(-/-)Akt1(-/-) strain might be of vascular origin. In the vessel wall, the loss of Akt1 increases inflammatory mediators and reduces eNOS phosphorylation, suggesting that Akt1 exerts vascular protection against atherogenesis. The presence of coronary lesions in ApoE(-/-)Akt1(-/-) mice provides a new model for studying the mechanisms of acute coronary syndrome in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054314      PMCID: PMC3621848          DOI: 10.1016/j.cmet.2007.10.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  39 in total

1.  Phenotypic and functional changes in regenerated porcine coronary endothelial cells : increased uptake of modified LDL and reduced production of NO.

Authors:  M P Fournet-Bourguignon; M Castedo-Delrieu; J P Bidouard; S Leonce; D Saboureau; I Delescluse; J P Vilaine; P M Vanhoutte
Journal:  Circ Res       Date:  2000-04-28       Impact factor: 17.367

Review 2.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques.

Authors:  O Tricot; Z Mallat; C Heymes; J Belmin; G Lesèche; A Tedgui
Journal:  Circulation       Date:  2000-05-30       Impact factor: 29.690

4.  Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt.

Authors:  Yasushi Mukai; Yoshiyuki Rikitake; Ichiro Shiojima; Sebastian Wolfrum; Minoru Satoh; Kyosuke Takeshita; Yukio Hiroi; Salvatore Salomone; Hyung-Hwan Kim; Laura E Benjamin; Kenneth Walsh; James K Liao
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

Review 5.  Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-01       Impact factor: 8.311

6.  Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.

Authors:  Thuy L Phung; Keren Ziv; Donnette Dabydeen; Godfred Eyiah-Mensah; Marcela Riveros; Carole Perruzzi; Jingfang Sun; Rita A Monahan-Earley; Ichiro Shiojima; Janice A Nagy; Michelle I Lin; Kenneth Walsh; Ann M Dvorak; David M Briscoe; Michal Neeman; William C Sessa; Harold F Dvorak; Laura E Benjamin
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

Review 7.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

8.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

9.  Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.

Authors:  Seongah Han; Chien-Ping Liang; Tracie DeVries-Seimon; Mollie Ranalletta; Carrie L Welch; Kadesha Collins-Fletcher; Domenico Accili; Ira Tabas; Alan R Tall
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

10.  Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.

Authors:  Eric Ackah; Jun Yu; Stefan Zoellner; Yasuko Iwakiri; Carsten Skurk; Rei Shibata; Noriyuki Ouchi; Rachael M Easton; Gennaro Galasso; Morris J Birnbaum; Kenneth Walsh; William C Sessa
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more
  137 in total

1.  Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis.

Authors:  Noemi Rotllan; Aránzazu Chamorro-Jorganes; Elisa Araldi; Amarylis C Wanschel; Binod Aryal; Juan F Aranda; Leigh Goedeke; Alessandro G Salerno; Cristina M Ramírez; William C Sessa; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

2.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

3.  TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.

Authors:  Christian P Bauerfeld; Ruchi Rastogi; Gaila Pirockinaite; Icksoo Lee; Maik Hüttemann; Bobby Monks; Morris J Birnbaum; Luigi Franchi; Gabriel Nuñez; Lobelia Samavati
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

4.  Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.

Authors:  Fei Wang; Yasuo Okamoto; Isao Inoki; Kazuaki Yoshioka; Wa Du; Xun Qi; Noriko Takuwa; Koichi Gonda; Yasuhiko Yamamoto; Ryunosuke Ohkawa; Takumi Nishiuchi; Naotoshi Sugimoto; Yutaka Yatomi; Kunitoshi Mitsumori; Masahide Asano; Makoto Kinoshita; Yoh Takuwa
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

Review 5.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

6.  Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats.

Authors:  Shobha Bhaskar; A Helen
Journal:  Mol Cell Biochem       Date:  2016-09-24       Impact factor: 3.396

7.  Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR.

Authors:  Chao-Yung Wang; Hyung-Hwan Kim; Yukio Hiroi; Naoki Sawada; Salvatore Salomone; Laura E Benjamin; Kenneth Walsh; Michael A Moskowitz; James K Liao
Journal:  Sci Signal       Date:  2009-03-17       Impact factor: 8.192

8.  Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.

Authors:  Edward Thorp; Dongying Cui; Dorien M Schrijvers; George Kuriakose; Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

9.  Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice.

Authors:  Kyoichiro Tsuchiya; Marit Westerterp; Andrew J Murphy; Vidya Subramanian; Anthony W Ferrante; Alan R Tall; Domenico Accili
Journal:  Circ Res       Date:  2013-02-18       Impact factor: 17.367

10.  The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Hsiang-Ling Wang; Tsung-Po Chen; Shun-Fa Yang; Shu-Chen Chu; Yih-Shou Hsieh
Journal:  J Clin Lab Anal       Date:  2013-02-19       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.